Robert P. Roche
Director/Miembro de la Junta en Catalent Maryland, Inc. .
Perfil
Robert P.
Roche is currently a Director at Catalent Maryland, Inc. and a Trustee at Bryn Mawr Hospital Foundation.
He is also a Member of Robert Roche Associates LLC.
Previously, he served as a Director at LifeCell Corp.
from 2005 to 2008, Director at Intercept Pharmaceuticals, Inc. from 2008 to 2011, Independent Director at EKR Therapeutics, Inc. in 2011, Independent Director at NuPathe, Inc. from 2010 to 2014, Independent Director at Aratana Therapeutics, Inc. from 2014 to 2019, and Independent Director at Zyla Life Sciences LLC from 2016 to 2019.
He also served as Director & Vice President at GSK Plc, Director & Managing Director at Smithkline Beecham Research Ltd., and Director at Civitas Therapeutics, Inc. from 2012 to 2014.
He was the Executive VP-Worldwide Pharmaceutical Operations at Cephalon, Inc. from 2005 to 2010.
He also served as a Director at Smithkline Beecham Pharmaceuticals (Canada).
He has been a Trustee at Westtown School.
He received his undergraduate degree from Colgate University and his MBA from The Wharton School of the University of Pennsylvania.
Cargos activos de Robert P. Roche
| Empresas | Cargo | Inicio |
|---|---|---|
| Robert Roche Associates LLC | Corporate Officer/Principal | 01/02/2010 |
| Bryn Mawr Hospital Foundation | Director/Miembro de la Junta | - |
Catalent Maryland, Inc.
 Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Robert P. Roche.
| Empresas | Cargo | Fin |
|---|---|---|
| ANTARES PHARMA, INC. | Director/Miembro de la Junta | 24/05/2022 |
| ARATANA THERAPEUTICS INC | Director/Miembro de la Junta | 18/07/2019 |
| ZYLA LIFE SCIENCES | Director/Miembro de la Junta | 31/01/2019 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Director/Miembro de la Junta | 01/11/2014 |
| NUPATHE INC | Director/Miembro de la Junta | 21/02/2014 |
Formación de Robert P. Roche.
| Colgate University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GSK PLC | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 14 |
|---|---|
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
| Smithkline Beecham Research Ltd. | |
| Smithkline Beecham Pharmaceuticals (Canada) | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
EKR Therapeutics, Inc.
 EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Health Services |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Westtown School
 Westtown School Miscellaneous Commercial ServicesCommercial Services Westtown School is a quaker, coeducational, college preparatory day and boarding school for students in pre-kindergarten through twelfth grade. The company was founded in May 1799 and is headquartered in West Chester, PA. | Commercial Services |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
| Robert Roche Associates LLC | |
| Bryn Mawr Hospital Foundation | |
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert P. Roche